proline has been researched along with Carotid Stenosis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kang, YJ; Kim, DI; Kim, SH; Kim, WJ; Kwon, BS; Lee, WH; Lee, Y; Park, JE; Park, YB; Woo, DK | 1 |
Aalami, OO; Eng, J; Hrabie, JA; Jiang, Q; Kapadia, MR; Keefer, LK; Kibbe, MR; Lyle, B; Murar, J; Najjar, SF; Pearce, CG; Saavedra, JE | 1 |
Karvonen, MK; Koulu, M; Laakso, M; Mercuri, M; Niskanen, L; Pesonen, U; Rauramaa, R; Töyry, J; Uusitupa, MI; Valve, R | 1 |
3 other study(ies) available for proline and Carotid Stenosis
Article | Year |
---|---|
TWEAK can induce pro-inflammatory cytokines and matrix metalloproteinase-9 in macrophages.
Topics: Aged; Aged, 80 and over; Apoptosis Regulatory Proteins; Carotid Stenosis; Carrier Proteins; Cell Line; Chemokine CCL2; Cytokine TWEAK; Cytokines; Enzyme Induction; Foam Cells; Gene Expression Profiling; Humans; I-kappa B Proteins; Interferon-gamma; Interleukins; Macrophages; Matrix Metalloproteinase 9; Middle Aged; Monocytes; NF-kappa B; Proline; Recombinant Proteins; Thiocarbamates; Transcriptional Activation; Tumor Necrosis Factors | 2004 |
Beneficial effect of a short-acting NO donor for the prevention of neointimal hyperplasia.
Topics: Acrylic Resins; Animals; Carotid Artery, Common; Carotid Stenosis; Diazonium Compounds; Dosage Forms; Drug Administration Schedule; Drug Delivery Systems; Half-Life; Hyperplasia; Immunophenotyping; Inflammation; Ki-67 Antigen; Leukocyte Common Antigens; Male; Nitric Oxide Donors; Proline; Rats; Rats, Sprague-Dawley; Tunica Intima | 2008 |
Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene is associated with enhanced carotid atherosclerosis in elderly patients with type 2 diabetes and control subjects.
Topics: Aged; Amino Acid Substitution; Arteriosclerosis; Autonomic Nervous System; Blood Pressure; Carotid Stenosis; Cohort Studies; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Genotype; Heart Rate; Humans; Leucine; Male; Neuropeptide Y; Polymorphism, Genetic; Proline; Risk Factors | 2000 |